Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2026)

Fennec Pharmaceuticals (FENC) has 7 years of Non-Current Assets data on file, last reported at $3.5 million in Q4 2025.

• Quarterly Non-Current Assets rose 326.76% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 326.76% YoY) and the FY2025 annual result came in at $3.5 million, up 326.76% from the prior year.
• Non-Current Assets grew to $3.5 million in Q4 2025, from $3.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $4.1 million in Q2 2025 to a low of $6000.0 in Q4 2023.
• A 5-year average of $998421.1 and a median of $211000.0 in 2022 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2023 — Non-Current Assets sank 97.16% — and 2024, when it soared 13600.0%.
• Tracing FENC's Non-Current Assets over 5 years: stood at $27000.0 in 2021, then surged by 681.48% to $211000.0 in 2022, then slumped by 97.16% to $6000.0 in 2023, then soared by 13600.0% to $822000.0 in 2024, then surged by 326.76% to $3.5 million in 2025.
• The last three Non-Current Assets figures came in at $3.5 million (Q4 2025), $3.2 million (Q3 2025), and $4.1 million (Q2 2025), per Business Quant data.